This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: I-Sens, Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Bo Weol Kang: Innovator in Continuous Glucose Monitoring Systems
Introduction
Bo Weol Kang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical technology, particularly in the area of continuous glucose monitoring systems. With a total of 3 patents to his name, Kang is recognized for his innovative approaches to improving health monitoring solutions.
Latest Patents
Kang's latest patents focus on a communication connection method for continuous blood glucose monitoring systems. This method involves several key steps. First, it establishes communication between a communication terminal and a sensor transmitter attached to the human body. The communication terminal receives information from the sensor transmitter to continuously monitor biometric information. Next, it determines whether the sensor transmitter is new or previously used based on the received information. Finally, if the sensor transmitter is already used, the communication connection is controlled based on the use information of that transmitter. This innovation is particularly advantageous as it allows for quick reconnection of communication between the sensor transmitter and the communication terminal if the connection is disrupted.
Career Highlights
Bo Weol Kang is currently employed at I-Sens, Inc., where he continues to develop cutting-edge technologies in the field of glucose monitoring. His work has been instrumental in advancing the capabilities of medical devices that assist individuals in managing their health.
Collaborations
Kang collaborates with talented colleagues, including Jeong Je Park and Ji Sun Park, who contribute to the innovative projects at I-Sens, Inc. Their teamwork fosters an environment of creativity and technological advancement.
Conclusion
Bo Weol Kang is a notable inventor whose work in continuous glucose monitoring systems has the potential to significantly enhance health management for individuals. His innovative patents and contributions to I-Sens, Inc. reflect his commitment to improving medical technology.